ALK-1/VEGF dual-targeting antibody (Kintor Pharmaceutical)

N/A

Report date: 2025/03/18 18:08:01

Base Information

Drug NameALK-1/VEGF dual-targeting antibody (Kintor Pharmaceutical)
Drug Alias NameALK-1/VEGF bispecific antibody (Kintor Pharmaceutical)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionActivin receptor-like kinase 1 inhibitorsVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptorActivin receptor-like kinase 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Koshine Biomedica Inc
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Koshine Biomedica Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A